CN101700395B - Ointment for curing hyperosteogeny - Google Patents
Ointment for curing hyperosteogeny Download PDFInfo
- Publication number
- CN101700395B CN101700395B CN2009101726804A CN200910172680A CN101700395B CN 101700395 B CN101700395 B CN 101700395B CN 2009101726804 A CN2009101726804 A CN 2009101726804A CN 200910172680 A CN200910172680 A CN 200910172680A CN 101700395 B CN101700395 B CN 101700395B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- colophonium
- oleum sesami
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 17
- 239000002674 ointment Substances 0.000 title abstract description 4
- 239000003814 drug Substances 0.000 claims abstract description 22
- 241000218176 Corydalis Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 17
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 16
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 10
- 241001057584 Myrrha Species 0.000 claims description 10
- 241000510609 Ferula Species 0.000 claims description 9
- 241000593508 Garcinia Species 0.000 claims description 9
- 235000000885 Garcinia xanthochymus Nutrition 0.000 claims description 9
- 241000219780 Pueraria Species 0.000 claims description 9
- 241000545442 Radix Species 0.000 claims description 9
- 239000011505 plaster Substances 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000010257 thawing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000004863 Frankincense Substances 0.000 abstract description 2
- 230000000202 analgesic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000227129 Aconitum Species 0.000 abstract 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000489492 Arisaema Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000007162 Ferula assa foetida Nutrition 0.000 abstract 1
- 244000228957 Ferula foetida Species 0.000 abstract 1
- 235000012850 Ferula foetida Nutrition 0.000 abstract 1
- 241000598860 Garcinia hanburyi Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 abstract 1
- 244000223014 Syzygium aromaticum Species 0.000 abstract 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 1
- 241000746716 Typhonium Species 0.000 abstract 1
- 235000019507 asafoetida Nutrition 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 239000008159 sesame oil Substances 0.000 abstract 1
- 235000011803 sesame oil Nutrition 0.000 abstract 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000002661 Spondylitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention is an ointment for curing hyperosteogeny and relates to a traditional Chinese medicine, which is prepared by the following raw materials in parts by weight: 40-60 parts of frankincense, 40-60 parts of commiphora molmol, 40-60 parts of szechuan lovage rhizome, 80-120 parts of rhizoma corydalis, 80-120 parts of curcuma longa, 80-120 parts of paeonia lactiflora, 80-120 parts of pedate pinallia jackinthepulpit rhizome, 80-120 parts of giant typhonium rhizome, 80-120 parts of monkshood, 40-60 parts of kusnezoff monkshood Root, 40-60 parts of rhizoma zingiberis, 80-120 parts of cinnamon, 80-120 parts of clove, 80-120 parts of Garden Balsam Stem, 80-120 parts of common clubmoss Herb, 80-120 parts of rhizoma kaempferiae, 80-120 parts of dahurian angelica, 80-120 parts of notopterygium, 80-120 parts of radix puerariae, 40-60 parts of rheum, 80-120 parts of Chinese asafoetida, 40-60 parts of garcinia hanburyi, 1350-1650 parts of sesame oil, 3350-3650 parts of rosin and 850-1150 parts of minimum. The ointment prepared by the invention has the advantages of simple preparation process, easy production, good analgesic effect, and high curative rate, 100% of total effective ratio proved by 338 clinic experiments, pure traditional Chinese medicine prescription, small toxic and side effects, low cost and easy acceptance of patients.
Description
Technical field:
The present invention relates to the Chinese medicine medicine, especially for the Chinese medicine ointment of treatment hyperosteogeny.
Background technology:
Hyperosteogeny is a great problem of current international medical community, mostly occurs person in middle and old age, and positions such as waist, lower limb, shoulder and arm, when beginning to take place, sensation ache, numbness can not be worked when serious, and difficulty in walking causes serious physiology and mental anguish to the patient.At present domestic and international each R﹠D institution of universities and colleges, the traditional Chinese medical science, doctor trained in Western medicine have all dropped into a large amount of funds and have carried out the emphasis tackling key problem, so far there is not ideal treatment way, part hospital takes methods such as operation, ozone, threading, plaster to treat, but unsatisfactory curative effects all, particularly the expenses of surgical treatment height has a big risk, cure the symptoms, not the disease, be difficult to eradicate.Lack person's half a year, many persons 2～3 years, often recurrence once more.The treatment how effectively to solve hyperosteogeny is many problems of being paid close attention to.
Summary of the invention:
The purpose of this invention is to provide a kind of plaster simple, easy to use, that cost is lower, effect is treated hyperosteogeny preferably of making.
The objective of the invention is to realize: a kind of plaster for the treatment of hyperosteogeny by following scheme, it is characterized in that it is made by the following weight proportion raw material: 40～60 parts of Olibanums, 40～60 parts of Myrrhas, 40～60 parts of Rhizoma Chuanxiongs, 80～120 parts of Rhizoma Corydalis, 80～120 parts in Rhizoma Curcumae Longae, 80～120 parts of Radix Polygoni Ciliinerve, 80～120 parts of Rhizoma Arisaematiss, 80～120 parts of Rhizoma Typhoniis, 80～120 parts of Radix Aconitis, 40～60 parts of Radix Aconiti Kusnezoffii, 40～60 parts of Rhizoma Zingiberiss, 80～120 parts of Cortex Cinnamomis, 80～120 parts of Flos Caryophyllis, 80～120 parts of Herba speranskiae tuberculataes, 80～120 parts of Herba Lycopodiis, 80～120 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 80～120 parts of the Radixs Angelicae Dahuricae, 80～120 parts of Rhizoma Et Radix Notopterygiis, 80～120 parts of Radix Puerariaes, 40～60 parts of Radix Et Rhizoma Rhei, 80～120 parts of Resina Ferulaes, 40～60 parts of Resina garciniaes, 1350～1650 parts of Oleum sesami, 3350～3650 parts of Colophonium, 850～1150 parts of Plumbum preparatiums.
Preferred version is: 45～55 parts of Olibanums, 45～55 parts of Myrrhas, 45～55 parts of Rhizoma Chuanxiongs, 90～110 parts of Rhizoma Corydalis, 90～110 parts in Rhizoma Curcumae Longae, 90～110 parts of Radix Polygoni Ciliinerve, 90～110 parts of Rhizoma Arisaematiss, 90～110 parts of Rhizoma Typhoniis, 90～110 parts of Radix Aconitis, 45～55 parts of Radix Aconiti Kusnezoffii, 45～55 parts of Rhizoma Zingiberiss, 90～110 parts of Cortex Cinnamomis, 90～110 parts of Flos Caryophyllis, 90～110 parts of Herba speranskiae tuberculataes, 90～110 parts of Herba Lycopodiis, 90～110 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 90～110 parts of the Radixs Angelicae Dahuricae, 90～110 parts of Rhizoma Et Radix Notopterygiis, 90～110 parts of Radix Puerariaes, 45～55 parts of Radix Et Rhizoma Rhei, 90～110 parts of Resina Ferulaes, 45～55 parts of Resina garciniaes, 1400～1600 parts of Oleum sesami, 3400～3600 parts of Colophonium, 900～1100 parts of Plumbum preparatiums.
Preferred plan is: 50 parts of Olibanums, 50 parts of Myrrhas, 50 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 100 parts in Rhizoma Curcumae Longae, 100 parts of Radix Polygoni Ciliinerve, 100 parts of Rhizoma Arisaematiss, 100 parts of Rhizoma Typhoniis, 100 parts of Radix Aconitis, 50 parts of Radix Aconiti Kusnezoffii, 50 parts of Rhizoma Zingiberiss, 100 parts of Cortex Cinnamomis, 100 parts of Flos Caryophyllis, 100 parts of Herba speranskiae tuberculataes, 100 parts of Herba Lycopodiis, 100 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 100 parts of the Radixs Angelicae Dahuricae, 100 parts of Rhizoma Et Radix Notopterygiis, 100 parts of Radix Puerariaes, 50 parts of Radix Et Rhizoma Rhei, 100 parts of Resina Ferulaes, 50 parts of Resina garciniaes, 1500 parts of Oleum sesami, 3500 parts of Colophonium, 1000 parts of Plumbum preparatiums.
Manufacture method: get the raw material except that Oleum sesami, Colophonium, Plumbum preparatium, all be ground into granule, it is standby to form the compound pack; Get Oleum sesami, Colophonium, Plumbum preparatium, put into pot with the slow fire heating, after the thawing, put into compound, intense fire behind the first slow fire boils medicine and becomes taupe, filter.Time spent spreads out on the thick cloth and gets final product.
The Difficult Classic cloud: " superintend and direct for exhausted; back rigidity and faint ", neck breast lumbar vertebra is sitting at the governor vessel meridians and follows on the line, the marrow insufficiency of essence, governor vessel loses supports, also can cause neck breast lumbar vertebra generation degeneration, caused by liver and kidney deficiency, insufficiency of vital energy and blood, wind-cold damp pathogen is also taken advantage of a weak point in opponent's defence and is attacked, the multiple abscess meridians cause QI-blood circulation not smooth, and acid, heavy, numbness and limitation of activity appear in the limbs that cause near the spinal column muscles and bones joint, muscle and dorsolumbar nerve domination.
According to above-mentioned etiology and pathology, just loose and amass, remove wind-cold damp pathogen, warm promoting blood circulation in the body with blood circulation promoting and blood stasis dispelling, eliminating stagnation, strengthening the body resistance can reach treating both the principal and secondary aspects of a disease.
The present invention is formed by following several big class compatibility of drugss: Olibanum, Myrrha, Rhizoma Chuanxiong, Rhizoma Corydalis, Rhizoma Curcumae Longae, Radix Polygoni Ciliinerve, above medicine blood circulation promoting and blood stasis dispelling, removing blood stasis pain relieving; Rhizoma Arisaematis, Rhizoma Typhonii warming for resolving cold-phlegm; Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Zingiberis, Cortex Cinnamomi, Flos Caryophylli, Herba speranskiae tuberculatae, Herba Lycopodii, Colophonium, Rhizoma Kaempferiae, above medicine expelling wind and dampness is opened expectorant, detumescence, temperature three-way meridian, and the recuperating depleted YANG tonify deficiency consolidates; The Radix Angelicae Dahuricae, Rhizoma Et Radix Notopterygii, the Radix Puerariae relieving the exterior syndrome with drugs of pungent in flavor and warm in nature; Radix Et Rhizoma Rhei is walked and is not kept, and gos deep into blood system, and the double edema caused by disorder of QI of walking breaks hard removing mass; The Resina Ferulae painful abdominal mass removing mass that disappears exorcises evil spirits; The Resina garciniae subduing swelling and detoxicating is controlled all swollen ulcer drugs, deep edema, dense swollen.Adjuvant Oleum sesami, Colophonium, Plumbum preparatium.More than all medicines share, complement each other, start with from the pathology cause of disease of hyperosteogeny, reach the purpose of thorough radical cure.
The medicine of taking the present invention to make has the following advantages: 1, processing technology is simple, is convenient to produce.2, good analgesic effect, the cure rate height.Show that with 338 routine clinical trials total effective rate is 100%.3, use pure Chinese medicine preparation, toxic and side effects is little.4, cost is low, and the patient is easy to accept.
Testing data:
1, cure mainly: the neck that cervical vertebra, thoracic vertebra, lumbar vertebra hyperosteogeny and prolapse of lumbar intervertebral disc, bulging cause, shoulder, waist, have a pain in the leg the pain; Osteoarthritis such as arthritis, spondylitis, lumbar muscle strain.
2, case statistics: select patient's standard: 1. following symptom is arranged: waist, lower limb, arm begin to ache, numb, pain, are difficult to activity when serious; 2. be defined as hyperosteogeny through perspective, film making, CT.
Treat 338 examples, among the patient, male's 205 examples, women's 133 examples, age distribution is: 10 examples below 30 years old, 31～40 years old 36 examples, 41～50 years old 52 example, 50～60 years old 133 example, 107 examples more than 60 years old, maximum 74 years old age, minimal ages 17 years old, sick elder 4 years, weak point person 3 months, the patient is in the majority with lumbar vertebra hyperosteogeny.
3, Therapeutic Method: cream 3～5 grams of getting it filled, on the cloth that evenly is applied to, form 4～5 centimetres of circles of about diameter, be affixed on the affected part again, changed dressings once in per three days, 25 days is a course of treatment.
4, contraindication: period in a medicine, diet, raw food, spicy food were not done ass work, did not have a bath with cold water.Anemia of pregnant woman's forbidding is forbidden this product allergy sufferers.
5, efficacy assessment standard:
Produce effects: pain disappears, and 3 months no rebound phenomenons are observed in joint and along freely.Take a turn for the better: intermission prolongation, pain disappear substantially, and life activity is obviously convenient.Invalid: as not reach improvement target person.
6, therapeutic effect:
68 days courses of treatment of mean treatment, the shortest 15 days, the longest 250 days, medication produce effects 279 examples account for 82.5%, and 59 examples that take a turn for the better account for 17.5%, invalid 0 example, total effective rate 100%.
7, model case introduction:
(1) limit so-and-so, the man 61 years old, inhabits oil field, Puyang, Henan Province three-hypers, cervical region lumbar vertebrae matter hypertrophy has caused that head is heavy, left hand refers to fiber crops, successively arrives the large hospital treatment in provincial capital and near city, does not all have positive effect, bring into use this medicine in March, 2007, obvious sensation was arranged in 7 days, 15 days transference cures, life is freely.
(2) grandson so-and-so, the woman 43 years old, inhabits long celebrating garden, Puyang, Henan Province, lumbar vertebra hyperosteogeny, bulging, hyperosteogeny reaches 6 months, pain often, and dizziness influences work and life, bring into use this medicine in June, 2007, pain disappears behind 1 first quarter moon, lives freely operate as normal.
(3) Zhang, the woman, 17 years old, inhabit Henan Province Puyang oil recovery designing institute sub-district, thoracic vertebra, lumbar vertebra distortion hypertrophy, studying and living is had a strong impact on, and brings into use this medicine, rehabilitation after 2 months in October, 2008.
(4) Lee so-and-so, the man, 74 years old, inhabit Henan Province's Puyang two companies of recovering the oil, protrusion of lumbar intervertebral disc influences sitting, brings into use this medicine, rehabilitation after 2 months in July, 2008.
The specific embodiment:
Below in conjunction with embodiment the present invention is done further narration:
Embodiment 1: choose 42 parts of Olibanums, 42 parts of Myrrhas, 42 parts of Rhizoma Chuanxiongs, 80 parts of Rhizoma Corydalis, 85 parts in Rhizoma Curcumae Longae, 85 parts of Radix Polygoni Ciliinerve, 85 parts of Rhizoma Arisaematiss, 85 parts of Rhizoma Typhoniis, 85 parts of Radix Aconitis, 42 parts of Radix Aconiti Kusnezoffii, 42 parts of Rhizoma Zingiberiss, 85 parts of Cortex Cinnamomis, 85 parts of Flos Caryophyllis, 85 parts of Herba speranskiae tuberculataes, 85 parts of Herba Lycopodiis, 85 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 85 parts of the Radixs Angelicae Dahuricae, 85 parts of Rhizoma Et Radix Notopterygiis, 85 parts of Radix Puerariaes, 42 parts of Radix Et Rhizoma Rhei, 85 parts of Resina Ferulaes, 42 parts of Resina garciniaes, 1380 parts of Oleum sesami, 3380 parts of Colophonium, 880 parts of Plumbum preparatiums.Manufacture method: get the raw material except that Oleum sesami, Colophonium, Plumbum preparatium, all be ground into granule, it is standby to form the compound pack; Get Oleum sesami, Colophonium, Plumbum preparatium, put into pot with the slow fire heating, after the thawing, put into compound, intense fire behind the first slow fire boils medicine and becomes taupe, filter.Time spent spreads out on the thick cloth and gets final product.
Embodiment 2: choose 58 parts of Olibanums, 58 parts of Myrrhas, 58 parts of Rhizoma Chuanxiongs, 120 parts of Rhizoma Corydalis, 115 parts in Rhizoma Curcumae Longae, 115 parts of Radix Polygoni Ciliinerve, 115 parts of Rhizoma Arisaematiss, 115 parts of Rhizoma Typhoniis, 115 parts of Radix Aconitis, 58 parts of Radix Aconiti Kusnezoffii, 58 parts of Rhizoma Zingiberiss, 115 parts of Cortex Cinnamomis, 115 parts of Flos Caryophyllis, 115 parts of Herba speranskiae tuberculataes, 115 parts of Herba Lycopodiis, 115 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 115 parts of the Radixs Angelicae Dahuricae, 115 parts of Rhizoma Et Radix Notopterygiis, 115 parts of Radix Puerariaes, 58 parts of Radix Et Rhizoma Rhei, 115 parts of Resina Ferulaes, 58 parts of Resina garciniaes, 1620 parts of Oleum sesami, 3620 parts of Colophonium, 1120 parts of Plumbum preparatiums.
Preparation method is with embodiment 1.
Embodiment 3: choose 48 parts of Olibanums, 48 parts of Myrrhas, 48 parts of Rhizoma Chuanxiongs, 95 parts of Rhizoma Corydalis, 95 parts in Rhizoma Curcumae Longae, 95 parts of Radix Polygoni Ciliinerve, 95 parts of Rhizoma Arisaematiss, 95 parts of Rhizoma Typhoniis, 95 parts of Radix Aconitis, 45 parts of Radix Aconiti Kusnezoffii, 48 parts of Rhizoma Zingiberiss, 95 parts of Cortex Cinnamomis, 95 parts of Flos Caryophyllis, 95 parts of Herba speranskiae tuberculataes, 95 parts of Herba Lycopodiis, 95 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 95 parts of the Radixs Angelicae Dahuricae, 95 parts of Rhizoma Et Radix Notopterygiis, 95 parts of Radix Puerariaes, 48 parts of Radix Et Rhizoma Rhei, 95 parts of Resina Ferulaes, 48 parts of Resina garciniaes, 1450 parts of Oleum sesami, 3450 parts of Colophonium, 950 parts of Plumbum preparatiums.
Preparation method is with embodiment 1.
Embodiment 4: choose 52 parts of Olibanums, 52 parts of Myrrhas, 52 parts of Rhizoma Chuanxiongs, 105 parts of Rhizoma Corydalis, 105 parts in Rhizoma Curcumae Longae, 105 parts of Radix Polygoni Ciliinerve, 105 parts of Rhizoma Arisaematiss, 105 parts of Rhizoma Typhoniis, 105 parts of Radix Aconitis, 55 parts of Radix Aconiti Kusnezoffii, 52 parts of Rhizoma Zingiberiss, 105 parts of Cortex Cinnamomis, 105 parts of Flos Caryophyllis, 105 parts of Herba speranskiae tuberculataes, 105 parts of Herba Lycopodiis, 105 parts of Rhizoma Kaempferiae (husky Rhizoma Zingiberis Recens), 105 parts of the Radixs Angelicae Dahuricae, 105 parts of Rhizoma Et Radix Notopterygiis, 105 parts of Radix Puerariaes, 52 parts of Radix Et Rhizoma Rhei, 105 parts of Resina Ferulaes, 52 parts of Resina garciniaes, 1550 parts of Oleum sesami, 3550 parts of Colophonium, 1050 parts of Plumbum preparatiums.
Preparation method is with embodiment 1.
Claims (3)
1. plaster for the treatment of hyperosteogeny, it is characterized in that it is made by the following weight proportion raw material: 40～60 parts of Olibanums, 40～60 parts of Myrrhas, 40～60 parts of Rhizoma Chuanxiongs, 80～120 parts of Rhizoma Corydalis, 80～120 parts in Rhizoma Curcumae Longae, 80～120 parts of Radix Polygoni Ciliinerve, 80～120 parts of Rhizoma Arisaematiss, 80～120 parts of Rhizoma Typhoniis, 80～120 parts of Radix Aconitis, 40～60 parts of Radix Aconiti Kusnezoffii, 40～60 parts of Rhizoma Zingiberiss, 80～120 parts of Cortex Cinnamomis, 80～120 parts of Flos Caryophyllis, 80～120 parts of Herba speranskiae tuberculataes, 80～120 parts of Herba Lycopodiis, 80～120 parts of Rhizoma Kaempferiae, 80～120 parts of the Radixs Angelicae Dahuricae, 80～120 parts of Rhizoma Et Radix Notopterygiis, 80～120 parts of Radix Puerariaes, 40～60 parts of Radix Et Rhizoma Rhei, 80～120 parts of Resina Ferulaes, 40～60 parts of Resina garciniaes, 1350～1650 parts of Oleum sesami, 3350～3650 parts of Colophonium, 850～1150 parts of Plumbum preparatiums.
2. a kind of plaster for the treatment of hyperosteogeny according to claim 1, the weight proportion that it is characterized in that raw material is: 50 parts of Olibanums, 50 parts of Myrrhas, 50 parts of Rhizoma Chuanxiongs, 100 parts of Rhizoma Corydalis, 100 parts in Rhizoma Curcumae Longae, 100 parts of Radix Polygoni Ciliinerve, 100 parts of Rhizoma Arisaematiss, 100 parts of Rhizoma Typhoniis, 100 parts of Radix Aconitis, 50 parts of Radix Aconiti Kusnezoffii, 50 parts of Rhizoma Zingiberiss, 100 parts of Cortex Cinnamomis, 100 parts of Flos Caryophyllis, 100 parts of Herba speranskiae tuberculataes, 100 parts of Herba Lycopodiis, 100 parts of Rhizoma Kaempferiae, 100 parts of the Radixs Angelicae Dahuricae, 100 parts of Rhizoma Et Radix Notopterygiis, 100 parts of Radix Puerariaes, 50 parts of Radix Et Rhizoma Rhei, 100 parts of Resina Ferulaes, 50 parts of Resina garciniaes, 1500 parts of Oleum sesami, 3500 parts of Colophonium, 1000 parts of Plumbum preparatiums.
3. a kind of preparation method for the treatment of the plaster of hyperosteogeny according to claim 1 and 2 is characterized in that: get the raw material except that Oleum sesami, Colophonium, Plumbum preparatium, all be ground into granule, it is standby to form the compound pack; Get Oleum sesami, Colophonium, Plumbum preparatium, put into pot with the slow fire heating, after the thawing, put into compound, intense fire behind the first slow fire boils medicine and becomes taupe, filter.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101726804A CN101700395B (en) | 2009-11-24 | 2009-11-24 | Ointment for curing hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101726804A CN101700395B (en) | 2009-11-24 | 2009-11-24 | Ointment for curing hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101700395A CN101700395A (en) | 2010-05-05 |
| CN101700395B true CN101700395B (en) | 2011-06-15 |
Family
ID=42155339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101726804A Expired - Fee Related CN101700395B (en) | 2009-11-24 | 2009-11-24 | Ointment for curing hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101700395B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103330923B (en) * | 2013-06-05 | 2016-02-03 | 黄培龙 | A kind ofly treat external-applied ointment of old osteoarthritis and preparation method thereof |
| CN103656001A (en) * | 2013-12-18 | 2014-03-26 | 青岛市市立医院 | Compound medicine for treating osteoproliferation |
-
2009
- 2009-11-24 CN CN2009101726804A patent/CN101700395B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101700395A (en) | 2010-05-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411802B (en) | Black plaster for treating hyperosteogeny and preparation method thereof | |
| CN102178894B (en) | Plaster and preparation method of plaster | |
| CN1118285C (en) | Shubi plaster for treating arthralgia due to wind-cold-dampness | |
| CN103908545B (en) | Drug for treating cervical and lumbar vertebra and knee hyperosteogeny and lumbar disc herniation | |
| CN104127622A (en) | Plaster for treatment of pains in necks, shoulders, waists and legs | |
| CN103263591B (en) | External-use medicine for treating neck/lumbar disc herniation and osteoarthropathy | |
| CN102600413B (en) | Fumigated Chinese herbal medicine for treating neck, shoulder, waist and leg pains and preparation method thereof | |
| CN101972464B (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
| CN102366603A (en) | Medicine for treating rheumatism, rheumatoid arthritis, pain in neck, shoulder, waist and lower extremities and preparation method thereof | |
| CN101549137A (en) | Chinese medicine preparation for treating bone joint disease | |
| CN101214318B (en) | Medicinal liquor for treating rheumatism, rheumatoid and various hyperosteogeny | |
| CN102872282B (en) | Han Shi Bi Ting Wan for treating ankylosing spondylitis | |
| CN102343008B (en) | Chinese medicinal composition for treating prolapse of lumbar intervertebral disc | |
| CN101700395B (en) | Ointment for curing hyperosteogeny | |
| CN102743554B (en) | Externally applied plaster treating rheumatic arthralgia | |
| CN101264166A (en) | Medical ointment for treating rheumatism | |
| CN104096022A (en) | External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof | |
| CN103356953A (en) | Chinese medicine composition for treating lumbar muscle degeneration | |
| CN101979081A (en) | Plaster for treating arthritis and hyperosteogeny | |
| CN102133380B (en) | Medicament for treating cervical spondylosis | |
| CN104606313A (en) | Traditional Chinese medicinal ointment for treating osteoarticular diseases and bone fractures | |
| CN104873699A (en) | Traditional Chinese medicine ointment and preparation method thereof | |
| CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
| CN102579613A (en) | Oral Chinese medicinal composition for treating rheumatism pain | |
| CN102580049B (en) | Externally applied traditional Chinese medicine combination for treating osteoarthritis through applying iontophoresis and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Taolin Inventor after: Mao Jingyu Inventor before: Zhang Taolin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG TAOLIN TO: ZHANG TAOLIN MAO JINGYU |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110615 Termination date: 20141124 |
|
| EXPY | Termination of patent right or utility model |